BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas

Nucleic Acids Research

Volumn 34, Issue 6, 2006, Pages 1745-1754

  Nowak, Katrin ^b   Kerl, Kornelius ^b   Fehr, Daniel ^b   Kramps, Christoph ^b   Gessner, Christine ^b   Killmer, Katrin ^b   Samans, Birgit ^b   Berwanger, Bernd ^a   Christiansen, Holger ^a   Lutz, Werner ^b  

^a Children's Hospital   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN BMI1; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; BMI1 PROTEIN, HUMAN; NUCLEAR PROTEIN; REPRESSOR PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA MICROARRAY; EMBRYO; GENE ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MOUSE; NEUROBLASTOMA; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; ANIMAL; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CHROMATIN; GENETICS; METABOLISM; NERVOUS SYSTEM TUMOR; TUMOR CELL LINE;

ANIMALIA;

ANIMALS; BINDING SITES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; CHROMATIN; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NERVOUS SYSTEM NEOPLASMS; NEUROBLASTOMA; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; TUMOR CELLS, CULTURED;

EID: 33645826712     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkl119     Document Type: Article

References (69)

1. Orlando,V. (2003) Polycomb, epigenomes, and control of cell identity. Cell, 112, 599-606.
2. Lund,A.H. and van Lohuizen,M. (2004) Polycomb complexes and silencing mechanisms. Curr. Opin. Cell Biol., 16, 239-246.
3. Otte,A.P. and Kwaks,T.H. (2003) Gene repression by Polycomb group protein complexes: A distinct complex for every occasion? Curr. Opin. Genet. Dev., 13, 448-454.
4. Shao,Z., Raible,F., Mollaaghababa,R., Guyon,J.R., Wu,C.T., Bender,W. and Kingston,R.E. (1999) Stabilization of chromatin structure by PRC1, a Polycomb complex. Cell, 98, 37-46.
5. Francis,N.J., Saurin,A.J., Shao,Z. and Kingston,R.E. (2001) Reconstitution of a functional core polycomb repressive complex. Mol. Cell, 8, 545-556.
6. Levine,S.S., Weiss,A., Erdjument-Bromage,H., Shao,Z., Tempst,P. and Kingston,R.E. (2002) The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans. Mol. Cell. Biol., 22, 6070-6078.
7. Lessard,J., Schumacher,A., Thorsteinsdottir,U., van Lohuizen,M., Magnuson,T. and Sauvageau,G. (1999) Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation. Genes Dev., 13, 2691-2703.
8. Haupt,Y., Alexander,W.S., Barri,G., Klinken,S.P. and Adams,J.M. (1991) Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell, 65, 753-763.
9. van Lohuizen,M., Verbeek,S., Scheijen,B., Wientjens,E., van der Gulden,H. and Berns,A. (1991) Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell, 65, 737-752.
10. Jacobs,J.J., Kieboom,K., Marino,S., DePinho,R.A. and van Lohuizen,M. (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature, 397, 164-168.
11. Molofsky,A.V., Pardal,R., Iwashita,T., Park,I.K., Clarke,M.F. and Morrison,S.J. (2003) Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature, 425, 962-967.
12. Kim,J.H., Yoon,S.Y., Kim,C.N., Joo,J.H., Moon,S.K., Choe,I.S., Choe,Y.K. and Kim,J.W. (2004) The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett., 203, 217-224.
13. Bea,S., Tort,F., Pinyol,M., Puig,X., Hernandez,L., Hernandez,S., Fernandez,P.L., van Lohuizen,M., Colomer,D. and Campo,E. (2001) BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res., 61, 2409-2412.
14. Vonlanthen,S., Heighway,J., Altermatt,H.J., Gugger,M., Kappeler,A., Borner,M.M., van Lohuizen,M. and Betticher,D.C. (2001) The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br. J. Cancer, 84, 1372-1376.
15. De Vos,J., Thykjaer,T., Tarte,K., Ensslen,M., Raynaud,P., Requirand,G., Pellet,F., Pantesco,V., Reme,T., Jourdan,M. et al. (2002) Comparison of gene expression profiling between malignant and normal plasma cells with oligonucleotide arrays. Oncogene, 21, 6848-6857.
16. Smith,K.S., Chanda,S.K., Lingbeek,M., Ross,D.T., Botstein,D., van Lohuizen,M. and Cleary,M.L. (2003) Bmi-1 regulation of INK4A-ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a-Pbx1. Mol. Cell, 12, 393-400.
17. Glinsky,G.V., Berezovska,O. and Glinskii,A.B. (2005) Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J. Clin. Invest., 115, 1503-1521.
18. Lessard,J. and Sauvageau,G. (2003) Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature, 423, 255-260.
19. Park,I.K., Qian,D., Kiel,M., Becker,M.W., Pihalja,M., Weissman,I.L., Morrison,S.J. and Clarke,M.F. (2003) Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature, 423, 302-305.
20. Valk-Lingbeek,M.E., Bruggeman,S.W. and van Lohuizen,M. (2004) Stem cells and cancer; the polycomb connection. Cell, 118, 409-418.
21. Lessard,J., Baban,S. and Sauvageau,G. (1998) Stage-specific expression of polycomb group genes in human bone marrow cells. Blood, 91, 1216-1224.
22. Leung,C., Lingbeek,M., Shakhova,O., Liu,J., Tanger,E., Saremaslani,P., Van Lohuizen,M. and Marino,S. (2004) Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature, 428, 337-341.
23. Brodeur,G.M. (2003) Neuroblastoma: Biological insights into a clinical enigma. Nature Rev. Cancer, 3, 203-216.
24. Ciccarone,V., Spengler,B.A., Meyers,M.B., Biedler,J.L. and Ross,R.A. (1989) Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res., 49, 219-225.
25. Dimitroulakos,J., Squire,J., Pawlin,G. and Yeger,H. (1994) NUB-7: A stable I-type human neuroblastoma cell line inducible along N- and S-type cell lineages. Cell Growth Differ., 5, 373-384.
26. Ross,R.A., Spengler,B.A., Domenech,C., Porubcin,M., Rettig,W.J. and Biedler,J.L. (1995) Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ., 6, 449-456.
27. Schwab,M. (2004) MYCN in neuronal tumours. Cancer Lett., 204, 179-187.
28. Trimarchi,J.M. and Lees,J.A. (2002) Sibling rivalry in the E2F family. Nature Rev. Mol. Cell. Biol., 3, 11-20.
29. DeGregori,J. (2002) The genetics of the E2F family of transcription factors: Shared functions and unique roles. Biochim. Biophys. Acta., 1602, 131-150.
30. Bracken,A.P., Ciro,M., Cocito,A. and Helin,K. (2004) E2F target genes: unraveling the biology. Trends Biochem. Sci., 29, 409-417.
31. Strieder,V. and Lutz,W. (2003) E2F proteins regulate MYCN expression in neuroblastomas. J. Biol. Chem., 278, 2983-2989.
32. Hernando,E., Nahle,Z., Juan,G., Diaz-Rodriguez,E., Alaminos,M., Hemann,M., Michel,L., Mittal,V., Gerald,W., Benezra,R. et al. (2004) Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature, 430, 797-802.
33. Lutz,W., Stohr,M., Schurmann,J., Wenzel,A., Lohr,A. and Schwab,M. (1996) Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene, 13, 803-812.
34. Kramps,C., Strieder,V., Sapetschnig,A., Suske,G. and Lutz,W. (2004) E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas. J. Biol. Chem., 279, 5110-5117.
35. Berwanger,B., Hartmann,O., Bergmann,E., Bernard,S., Nielsen,D., Krause,M., Kartal,A., Flynn,D., Wiedemeyer,R., Schwab,M. et al. (2002) Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. Cancer Cell, 2, 377-386.
36. Takahashi,Y., Rayman,J.B. and Dynlacht,B.D. (2000) Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression. Genes Dev., 14, 804-816.
37. Kondo,Y. and Issa,J.P. (2003) Enrichment for histone H3 lysine 9 methylation at Alu repeats in human cells. J. Biol. Chem., 278, 27658-27662.
38. Bergmann,E., Wanzel,M., Weber,A., Shin,I., Christiansen,H. and Eilers,M. (2001) Expression of P27(KIP1) is prognostic and independent of MYCN amplification in human neuroblastoma. Int. J. Cancer, 95, 176-183.
39. Mendez,J. and Stillman,B. (2000) Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: Assembly of prereplication complexes in late mitosis. Mol. Cell. Biol., 20, 8602-8612.
40. Muller,H., Bracken,A.P., Vernell,R., Moroni,M.C., Christians,F., Grassilli,E., Prosperini,E., Vigo,E., Oliner,J.D. and Helin,K. (2001) E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev., 15, 267-285.
41. Dennis,G.,Jr, Sherman,B.T., Hosack,D.A., Yang,J., Gao,W., Lane,H.C. and Lempicki,R.A. (2003) DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol., 4, P3.
42. Hsu,S.I., Yang,C.M., Sim,K.G., Hentschel,D.M., O'Leary,E. and Bonventre,J.V. (2001) TRIP-Br: A novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1. EMBO J., 20, 2273-2285.
43. Garcia,E., Marcos-Gutierrez,C., del Mar Lorente,M., Moreno,J.C. and Vidal,M. (1999) RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1. EMBO J., 18, 3404-3418.
44. Schlisio,S., Halperin,T., Vidal,M. and Nevins,J.R. (2002) Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function. EMBO J., 21, 5775-5786.
45. Trimarchi,J.M., Fairchild,B., Wen,J. and Lees,J.A. (2001) The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc. Natl Acad. Sci. USA, 98, 1519-1524.
46. Bracken,A.P., Pasini,D., Capra,M., Prosperini,E., Colli,E. and Helin,K. (2003) EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J., 22, 5323-5335.
47. Akasaka,T., van Lohuizen,M., van der Lugt,N., Mizutani-Koseki,Y., Kanno,M., Taniguchi,M., Vidal,M., Alkema,M., Berns,A. and Koseki,H. (2001) Mice doubly deficient for the Polycomb Group genes Mel18 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression. Development, 128, 1587-1597.
48. Kajiume,T., Ninomiya,Y., Ishihara,H., Kanno,R. and Kanno,M. (2004) Polycomb group gene mel-18 modulates the self-renewal activity and cell cycle status of hematopoietic stem cells. Exp. Hematol., 32, 571-578.
49. Taubert,S., Gorrini,C., Frank,S.R., Parisi,T., Fuchs,M., Chan,H.M., Livingston,D.M. and Amati,B. (2004) E2F-dependent histone acetylation and recruitment of the Tip60 acetyltransferase complex to chromatin in late G1. Mol. Cell. Biol., 24, 4546-4556.
50. Cam,H., Balciunaite,E., Blais,A., Spektor,A., Scarpulla,R.C., Young,R., Kluger,Y. and Dynlacht,B.D. (2004) A common set of gene regulatory networks links metabolism and growth inhibition. Mol. Cell, 16, 399-411.
51. Balciunaite,E., Spektor,A., Lents,N.H., Cam,H., Te Riele,H., Scime,A., Rudnicki,M.A., Young,R. and Dynlacht,B.D. (2005) Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells. Mol. Cell. Biol., 25, 8166-8178.
52. Dimova,D.K., Stevaux,O., Frolov,M.V. and Dyson,N.J. (2003) Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway. Genes Dev., 17, 2308-2320.
53. Fajas,L., Landsberg,R.L., Huss-Garcia,Y., Sardet,C., Lees,J.A. and Auwerx,J. (2002) E2Fs regulate adipocyte differentiation. Dev. Cell, 3, 39-49.
54. Suzuki,A. and Hemmati-Brivanlou,A. (2000) Xenopus embryonic E2F is required for the formation of ventral and posterior cell fates during early embryogenesis. Mol. Cell, 5, 217-229.
55. Rhodes,D.R., Kalyana-Sundaram,S., Mahavisno,V., Barrette,T.R., Ghosh,D. and Chinnaiyan,A.M. (2005) Mining for regulatory programs in the cancer transcriptome. Nature Genet., 37, 579-583.
56. Aslanian,A., Iaquinta,P.J., Verona,R. and Lees,J.A. (2004) Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics. Genes Dev., 18, 1413-1422.
57. Seum,C., Spierer,A., Pauli,D., Szidonya,J., Reuter,G. and Spierer,P. (1996) Position-effect variegation in Drosophila depends on dose of the gene encoding the E2F transcriptional activator and cell cycle regulator. Development, 122, 1949-1956.
58. Jacobs,J.J., Scheijen,B., Voncken,J.W., Kieboom,K., Berns,A. and van Lohuizen,M. (1999) Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev., 13, 2678-2690.
59. Lutz,W., Fulda,S., Jeremias,I., Debatin,K.M. and Schwab,M. (1998) MycN and IFNgamma cooperate in apoptosis of human neuroblastoma cells. Oncogene, 17, 339-346.
60. Fulda,S., Lutz,W., Schwab,M. and Debatin,K.M. (1999) MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene, 18, 1479-1486.
61. Leone,G., Sears,R., Huang,E., Rempel,R., Nuckolls,F., Park,C.H., Giangrande,P., Wu,L., Saavedra,H.I., Field,S.J. et al. (2001) Myc requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell, 8, 105-113.
62. Beier,R., Burgin,A., Kiermaier,A., Fero,M., Karsunky,H., Saffrich,R., Moroy,T., Ansorge,W., Roberts,J. and Eilers,M. (2000) Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events. EMBO J., 19, 5813-5823.
63. Ishida,S., Huang,E., Zuzan,H., Spang,R., Leone,G., West,M. and Nevins,J.R. (2001) Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol. Cell. Biol., 21, 4684-4699.
64. Weinmann,A.S., Bartley,S.M., Zhang,T., Zhang,M.Q. and Farnham,P.J. (2001) Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol. Cell. Biol., 21, 6820-6832.
65. Ren,B., Cam,H., Takahashi,Y., Volkert,T., Terragni,J., Young,R.A. and Dynlacht,B.D. (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev., 16, 245-256.
66. Stanelle,J., Stiewe,T., Theseling,C.C., Peter,M. and Putzer,B.M. (2002) Gene expression changes in response to E2F1 activation. Nucleic Acids Res., 30, 1859-1867.
67. 1/S transition and DNA replication. Cancer Cell, 3, 311-316.
68. Lee,T.I., Rinaldi,N.J., Robert,F., Odom,D.T., Bar-Joseph,Z., Gerber,G.K., Hannett,N.M., Harbison,C.T., Thompson,C.M., Simon,I. et al. (2002) Transcriptional regulatory networks in Saccharomyces cerevisiae. Science, 298, 799-804.
69. Dahiya,A., Wong,S., Gonzalo,S., Gavin,M. and Dean,D.C. (2001) Linking the Rb and polycomb pathways. Mol. Cell, 8, 557-569.